
Harrow Health, Inc.
HROWHealthcare|Drug Manufacturers - Specialty & Generic|US
$26.89
+0.85 (+3.26%)
Cash / Share
$2.25
Ownership Breakdown
78.0%
Float
37.5M
Shares Outstanding
29.2M
Float Shares
Major Holders (7)
Combined: 44.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Mark L. Baum | Individual | 10.69% | 4,056,962 | Apr 7, 2025 | 13D/G |
| BlackRock, Inc. | Holding company | 7.40% | 2,757,783 | Oct 27, 2026 | 13D/G |
| Opaleye Management Inc. | IA, CO | 5.62% | 2,105,000 | Nov 6, 2026 | 13D/G |
| James Silverman | Individual | 5.62% | 2,105,000 | Nov 6, 2026 | 13D/G |
| Opaleye, L.P. | Partnership | 5.62% | 2,105,000 | Nov 6, 2026 | 13D/G |
| Daniel Kaufman | Individual | 5.04% | 1,878,000 | Mar 11, 2026 | 13D/G |
| Daniel L. Kaufman | Individual | 4.75% | 1,684,424 | Dec 5, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,230,750 acquired · 883,569 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | Aug 14, 2026 | OPTION EX. | 11,250 | $35.96 | $404.6K | Form 4 |
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | Aug 14, 2026 | OPTION EX. | 11,250 | $35.96 | $404.6K | Form 4 |
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | Aug 14, 2026 | SELL | 11,250 | $40.00 | $450.0K | Form 4 |
| Sternberg Perry J. | director | Jun 18, 2026 | AWARD | 5,248 | — | — | Form 4 |
| SILVERNAIL LAUREN P | director | Jun 18, 2026 | AWARD | 5,248 | — | — | Form 4 |
| Graves Adrienne L | director | Jun 18, 2026 | AWARD | 5,248 | — | — | Form 4 |
| Graves Adrienne L | director | May 18, 2026 | BUY | 1,000 | $31.07 | $31.1K | Form 4 |
| SILVERNAIL LAUREN P | director | May 18, 2026 | BUY | 1,000 | $31.00 | $31.0K | Form 4 |
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | May 15, 2026 | AWARD | 10,000 | — | — | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | May 14, 2026 | BUY | 10,000 | $30.20 | $302.0K | Form 4 |
| BOLL ANDREW R. | PRESIDENT AND CFO | May 14, 2026 | BUY | 3,500 | $29.90 | $104.7K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 3, 2026 | SELL | 59,000 | $39.15 | $2.3M | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 4, 2026 | SELL | 134,000 | $39.67 | $5.3M | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 3, 2026 | SELL | 1,309 | $39.15 | $51.3K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 4, 2026 | SELL | 4,263 | $39.67 | $169.1K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Feb 27, 2026 | SELL | 5,000 | $54.18 | $270.9K | Form 4 |
| Sullivan Patrick William | CHIEF COMMERCIAL OFFICER | Jan 30, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Sullivan Patrick William | CHIEF COMMERCIAL OFFICER | Jan 30, 2026 | AWARD | 15,000 | — | — | Form 4 |
| Sullivan Patrick William | CHIEF COMMERCIAL OFFICER | Jan 30, 2026 | OTHER | 30,000 | $39.00 | $1.2M | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Jan 6, 2026 | SELL | 20,000 | $53.35 | $1.1M | Form 4 |
| BOLL ANDREW R. | PRESIDENT AND CFO | Dec 12, 2025 | OPTION EX. | 60,000 | $3.95 | $237.0K | Form 4 |
| BOLL ANDREW R. | PRESIDENT AND CFO | Dec 12, 2025 | TAX W/H | 26,665 | $47.06 | $1.3M | Form 4 |
| BOLL ANDREW R. | PRESIDENT AND CFO | Dec 12, 2025 | OPTION EX. | 60,000 | $3.95 | $237.0K | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Dec 12, 2025 | OPTION EX. | 180,000 | $3.95 | $711.0K | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Dec 12, 2025 | TAX W/H | 79,994 | $47.06 | $3.8M | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Dec 12, 2025 | OPTION EX. | 180,000 | $3.95 | $711.0K | Form 4 |
| Mullery Francis William Jr | CEO, ImprimisRx | Oct 6, 2025 | OTHER | 33,000 | $48.18 | $1.6M | Form 4 |
| Pollard Randall E. | CHIEF ACCOUNTING OFFICER | Sep 1, 2025 | AWARD | 30,000 | $39.00 | $1.2M | Form 4 |
| Pollard Randall E. | officer | Sep 1, 2025 | OTHER | 0 | — | — | Form 4 |
| BAUM MARK L | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jul 21, 2025 | OPTION EX. | 600,000 | $7.87 | $4.7M | Form 4 |
| BAUM MARK L | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jul 21, 2025 | TAX W/H | 313,338 | $37.08 | $11.6M | Form 4 |
| BAUM MARK L | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Jul 31, 2015 | OPTION EX. | 600,000 | $7.87 | $4.7M | Form 4 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER | Jul 1, 2025 | AWARD | 405,750 | — | — | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Jul 1, 2025 | AWARD | 889,500 | — | — | Form 4 |
| Sternberg Perry J. | director | Jun 20, 2025 | AWARD | 7,339 | — | — | Form 4 |
| SILVERNAIL LAUREN P | director | Jun 20, 2025 | AWARD | 7,339 | — | — | Form 4 |
| Graves Adrienne L | director | Jun 20, 2025 | AWARD | 7,339 | — | — | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Jun 9, 2025 | SELL | 15,204 | $30.37 | $461.8K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Jun 10, 2025 | SELL | 15,000 | $30.80 | $462.0K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Jun 3, 2025 | SELL | 3,000 | $30.04 | $90.1K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Jun 4, 2025 | SELL | 1,796 | $30.02 | $53.9K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | May 12, 2025 | SELL | 10,000 | $25.90 | $259.0K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | May 13, 2025 | SELL | 5,000 | $26.59 | $132.9K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 24, 2025 | SELL | 5,000 | $30.01 | $150.1K | Form 4 |
| BOLL ANDREW R. | Chief Financial Officer | Apr 3, 2025 | OPTION EX. | 346,500 | — | — | Form 4 |
| BOLL ANDREW R. | Chief Financial Officer | Apr 7, 2025 | TAX W/H | 136,745 | $23.09 | $3.2M | Form 4 |
| BOLL ANDREW R. | Chief Financial Officer | Apr 3, 2025 | OPTION EX. | 346,500 | — | — | Form 4 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx | Apr 3, 2025 | OPTION EX. | 277,200 | — | — | Form 4 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx | Apr 7, 2025 | TAX W/H | 109,475 | $23.09 | $2.5M | Form 4 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx | Apr 3, 2025 | OPTION EX. | 277,200 | — | — | Form 4 |
| BAUM MARK L | director, 10 percent owner, officer: Chief Executive Officer | Apr 3, 2025 | OPTION EX. | 762,300 | — | — | Form 4 |
| BAUM MARK L | director, 10 percent owner, officer: Chief Executive Officer | Apr 7, 2025 | TAX W/H | 300,363 | $23.09 | $6.9M | Form 4 |
| BAUM MARK L | director, 10 percent owner, officer: Chief Executive Officer | Apr 3, 2025 | OPTION EX. | 762,300 | — | — | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 18, 2025 | SELL | 5,000 | $30.01 | $150.1K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 18, 2025 | SELL | 5,000 | $29.64 | $148.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Feb 28, 2025 | SELL | 5,000 | $28.05 | $140.3K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Jan 22, 2025 | SELL | 20,000 | $35.59 | $711.8K | Form 4 |
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | Jan 6, 2025 | AWARD | 30,000 | $35.96 | $1.1M | Form 4 |
| Shojaei Amir | officer | Jan 6, 2025 | OTHER | 0 | — | — | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Sep 11, 2024 | OPTION EX. | 90,000 | $7.37 | $663.3K | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Sep 11, 2024 | TAX W/H | 45,140 | $41.37 | $1.9M | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Sep 11, 2024 | OPTION EX. | 90,000 | $7.37 | $663.3K | Form 4 |
| Sternberg Perry J. | director | Jun 14, 2024 | AWARD | 8,347 | — | — | Form 4 |
| Makary Martin A. | director | Jun 14, 2024 | AWARD | 8,347 | — | — | Form 4 |
| Graves Adrienne L | director | Jun 14, 2024 | AWARD | 8,347 | — | — | Form 4 |
| SILVERNAIL LAUREN P | director | Jun 14, 2024 | AWARD | 8,347 | — | — | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Apr 25, 2024 | BUY | 20,000 | $9.97 | $199.4K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Apr 24, 2024 | BUY | 8,285 | $10.15 | $84.1K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Apr 23, 2024 | BUY | 11,715 | $10.29 | $120.5K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Apr 19, 2024 | BUY | 29,400 | $10.56 | $310.4K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 28, 2024 | BUY | 50,000 | $12.82 | $641.0K | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Mar 22, 2024 | BUY | 9,000 | $11.59 | $104.3K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Mar 20, 2024 | BUY | 50,600 | $9.65 | $488.3K | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Mar 1, 2024 | OPTION EX. | 5,000 | $8.75 | $43.8K | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Mar 1, 2024 | OPTION EX. | 5,000 | $8.75 | $43.8K | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Feb 20, 2024 | OPTION EX. | 30,000 | $10.67 | $320.1K | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Feb 20, 2024 | OPTION EX. | 12,616 | $10.67 | $134.6K | Form 4 |
| SAHAREK JOHN P. | CEO of ImprimisRx | Feb 20, 2024 | OPTION EX. | 30,000 | — | — | Form 4 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER | Feb 20, 2024 | OPTION EX. | 45,000 | $10.67 | $480.1K | Form 4 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER | Feb 20, 2024 | OPTION EX. | 18,480 | $10.67 | $197.2K | Form 4 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER | Feb 20, 2024 | OPTION EX. | 45,000 | — | — | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Feb 20, 2024 | OPTION EX. | 150,000 | $10.67 | $1.6M | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Feb 20, 2024 | OPTION EX. | 59,836 | $10.67 | $638.5K | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Feb 20, 2024 | OPTION EX. | 150,000 | — | — | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Feb 7, 2024 | OPTION EX. | 15,400 | $7.71 | $118.7K | Form 4 |
| BAUM MARK L | director, officer: CHIEF EXECUTIVE OFFICER | Feb 7, 2024 | OPTION EX. | 15,400 | $7.71 | $118.7K | Form 4 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER | Feb 7, 2024 | OPTION EX. | 7,400 | $7.71 | $57.1K | Form 4 |
| BOLL ANDREW R. | CHIEF FINANCIAL OFFICER | Feb 7, 2024 | OPTION EX. | 7,400 | $7.71 | $57.1K | Form 4 |
| Graves Adrienne L | director | Jan 26, 2024 | AWARD | 3,119 | — | — | Form 4 |
| SILVERNAIL LAUREN P | director | Jan 26, 2024 | AWARD | 3,119 | — | — | Form 4 |
| SILVERNAIL LAUREN P | director: | Jan 26, 2024 | OTHER | 0 | — | — | Form 4 |
| Graves Adrienne L | director: | Jan 26, 2024 | OTHER | 0 | — | — | Form 4 |
| BAUM MARK L | director, officer: Chief Executive Officer | Nov 16, 2023 | BUY | 7,500 | $8.11 | $60.8K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Nov 15, 2023 | BUY | 25,000 | $8.03 | $200.7K | Form 4 |
| SAHAREK JOHN P. | Chief Commercial Officer | Nov 10, 2023 | OPTION EX. | 20,000 | — | — | Form 4 |
| SAHAREK JOHN P. | Chief Commercial Officer | Nov 10, 2023 | TAX W/H | 9,778 | $12.83 | $125.5K | Form 4 |
| SAHAREK JOHN P. | Chief Commercial Officer | Nov 10, 2023 | OPTION EX. | 20,000 | $4.16 | $83.2K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 20, 2023 | BUY | 5,983 | $14.49 | $86.7K | Form 4 |
| Opaleye Management Inc. | 10 percent owner | Sep 19, 2023 | BUY | 14,017 | $14.65 | $205.4K | Form 4 |
| BAUM MARK L | director, officer: Chief Executive Officer | Aug 14, 2023 | BUY | 5,800 | $17.05 | $98.9K | Form 4 |